UK markets open in 6 hours 17 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.10 +0.15 (+0.19%) GOLD FUTURES
2,310.30 +0.70 (+0.03%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
46,962.93 +854.54 (+1.85%)
Intra-Cellular Therapies, Inc. (ITCI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.67B |
| Enterprise value | 7.19B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.07 |
| Price/book (mrq) | 12.97 |
| Enterprise value/revenue | 15.56 |
| Enterprise value/EBITDA | -45.26 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.01 |
| 52-week change 3 | 17.36% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 84.89 |
| 52-week low 3 | 45.50 |
| 50-day moving average 3 | 69.30 |
| 200-day moving average 3 | 62.42 |
Share statistics
| Avg vol (3-month) 3 | 969.98k |
| Avg vol (10-day) 3 | 1.38M |
| Shares outstanding 5 | 105.57M |
| Implied shares outstanding 6 | 105.57M |
| Float 8 | 94.76M |
| % held by insiders 1 | 2.32% |
| % held by institutions 1 | 91.20% |
| Shares short (15 Apr 2024) 4 | 3.59M |
| Short ratio (15 Apr 2024) 4 | 6.03 |
| Short % of float (15 Apr 2024) 4 | 4.27% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.68% |
| Shares short (prior month 15 Mar 2024) 4 | 3.31M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -30.08% |
| Operating margin (ttm) | -25.81% |
Management effectiveness
| Return on assets (ttm) | -13.43% |
| Return on equity (ttm) | -22.39% |
Income statement
| Revenue (ttm) | 464.37M |
| Revenue per share (ttm) | 4.84 |
| Quarterly revenue growth (yoy) | 50.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -158.85M |
| Net income avi to common (ttm) | -139.67M |
| Diluted EPS (ttm) | -1.46 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 497.94M |
| Total cash per share (mrq) | 5.14 |
| Total debt (mrq) | 16.94M |
| Total debt/equity (mrq) | 2.86% |
| Current ratio (mrq) | 5.41 |
| Book value per share (mrq) | 6.14 |
Cash flow statement
| Operating cash flow (ttm) | -124.2M |
| Levered free cash flow (ttm) | -28.97M |
© 2024 Yahoo. All rights reserved.